75.06
전일 마감가:
$76.84
열려 있는:
$75.315
하루 거래량:
150.37K
Relative Volume:
0.92
시가총액:
$830.14M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.12%
1개월 성능:
+14.11%
6개월 성능:
+206.87%
1년 성능:
+0.00%
Palvella Therapeutics Inc Stock (PVLA) Company Profile
명칭
Palvella Therapeutics Inc
전화
(484) 253-1461
주소
125 STRAFFORD AVE, WAYNE
PVLA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PVLA
Palvella Therapeutics Inc
|
75.06 | 849.82M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-09 | 개시 | Oppenheimer | Outperform |
| 2025-08-06 | 개시 | Raymond James | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-04-09 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-26 | 개시 | Stifel | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-20 | 개시 | Canaccord Genuity | Buy |
| 2025-02-05 | 개시 | TD Cowen | Buy |
| 2024-12-26 | 개시 | H.C. Wainwright | Buy |
| 2024-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-03-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | 개시 | Robert W. Baird | Outperform |
| 2018-03-19 | 개시 | Evercore ISI | Outperform |
| 2018-03-19 | 개시 | Jefferies | Buy |
| 2018-01-16 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-30 | 개시 | Rodman & Renshaw | Buy |
| 2016-08-05 | 재개 | ROTH Capital | Buy |
| 2015-08-12 | 개시 | JMP Securities | Mkt Outperform |
| 2015-07-27 | 개시 | Oppenheimer | Outperform |
| 2015-07-22 | 개시 | ROTH Capital | Buy |
모두보기
Palvella Therapeutics Inc 주식(PVLA)의 최신 뉴스
Palvella Therapeutics (NASDAQ:PVLA) Sees Strong Trading VolumeHere's Why - MarketBeat
Palvella Therapeutics to Host Third Quarter 2025 Financial Results and Corporate Update Conference Call on November 11, 2025 - MarketScreener
Palvella Therapeutics to Host Third Quarter 2025 Financial - GlobeNewswire
Why Palvella Therapeutics Inc. stock remains a top recommendationEarnings Trend Report & Real-Time Buy Signal Alerts - newser.com
Will Palvella Therapeutics Inc. stock go up soonEarnings Overview Summary & Weekly Top Gainers Trade List - newser.com
What MACD and RSI say about Palvella Therapeutics Inc.2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Can Palvella Therapeutics Inc. stock deliver consistent earnings growthQuarterly Market Review & Trade Opportunity Analysis - newser.com
Tools to monitor Palvella Therapeutics Inc. recovery probabilityWeekly Trade Summary & AI Powered Buy and Sell Recommendations - newser.com
Can Palvella Therapeutics Inc. stock rebound after recent weaknessEarnings Summary Report & High Accuracy Trade Signal Alerts - newser.com
Can Palvella Therapeutics Inc. stock sustain market leadershipJuly 2025 Sector Moves & Verified Stock Trade Ideas - newser.com
Can momentum traders help lift Palvella Therapeutics Inc.July 2025 Pullbacks & Verified Chart Pattern Signals - newser.com
Trend analysis for Palvella Therapeutics Inc. this week2025 Biggest Moves & Short-Term Trading Alerts - newser.com
How Palvella Therapeutics Inc. stock performs in stagflationQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Short interest data insights for Palvella Therapeutics Inc.Portfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
How Palvella Therapeutics Inc. (PI6) stock compares with top peersWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Will a bounce in Palvella Therapeutics Inc. offer an exitJuly 2025 Rallies & Safe Capital Allocation Plans - newser.com
How institutional ownership impacts Palvella Therapeutics Inc. stockJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
Can Palvella Therapeutics Inc. stock maintain growth trajectoryBear Alert & Momentum Based Trading Ideas - newser.com
Is Palvella Therapeutics Inc. (PI6) stock a good hedge against inflationJuly 2025 Trends & Precise Trade Entry Recommendations - newser.com
Why Palvella Therapeutics Inc. (PI6) stock is favored by hedge fundsWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
Forecasting Palvella Therapeutics Inc. price range with options dataMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Can Palvella Therapeutics Inc. stock withstand economic slowdown2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Real time social sentiment graph for Palvella Therapeutics Inc.Earnings Miss & Stock Portfolio Risk Management - newser.com
Palvella Therapeutics (NASDAQ:PVLA) Hits New 52-Week HighWhat's Next? - MarketBeat
Why Palvella Therapeutics Inc. (PI6) stock is upgraded to buyInsider Buying & AI Enhanced Trade Execution Alerts - newser.com
How strong is Palvella Therapeutics Inc. stock balance sheet2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Multi factor analysis applied to Palvella Therapeutics Inc.Earnings Miss & AI Driven Stock Price Forecasts - newser.com
Palvella Therapeutics Inc (PVLA) 재무 분석
Palvella Therapeutics Inc (PVLA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):